The hsa_circ_0070354/ miR ‐4322/ RAB3B Axis Facilitates the Carcinogenesis and Development of Non‐Small Cell Lung Cancer ( NSCLC )
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.71980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 02.06.2026. Verfasst von Yuejiao Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, MicroRNAs, RNA, Circular, Lung Neoplasms. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Support Program of Jiangsu Province, Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (Originalsprache)
Background
Circular RNA (hsa_circ_0070354), also known as circPTPN13, was demonstrated in our previous study that it can be used as a biomarker for diagnosing non‐small cell lung cancer (NSCLC). However, the mechanism of its role in the occurrence and development of NSCLC has not been investigated. Methods and Results The cell functions of NSCLC cells are evaluated by transfecting with relevant mimics, inhibitors, or plasmids in cell lines. After knocking down hsa_circ_0070354, the expression of miR‐4322 increased, and RAB3B decreased, and the expression changed inversely after overexpression of hsa_circ_0070354. Mechanically, hsa_circ_0070354 acts as a ceRNA to adsorb miR‐4322 and modulate Ras‐Related Protein Rab‐3B (RAB3B) to facilitate the proliferation, migration, invasion, and EMT of NSCLC cells. MiR‐4322 or RAB3B inhibition restored proliferation, migration, and invasion of NSCLC cells after silencing of hsa_circ_0070354. In addition, hsa_circ_0070354 knockdown suppressed tumor growth in vivo.
Conclusions
Collectively, our study reveals a promotive role of hsa_circ_0070354 in tumor proliferation, invasion, and migration by regulating the miR ‐4322/ RAB3B axis and highlights that targeting the axis is a promising strategy for the intervention of NSCLC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China.
- Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China.
- Department of Medical Oncology, Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu, China.
ORCID-Profile: Yuejiao Huang, Shaoqing Ju
Förderung
- National Natural Science Foundation of China
- Science and Technology Support Program of Jiangsu Province
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Huang, Y., Qin, S., Zhang, Y., Gu, X., Zheng, M., Ling, G., Yang, L., & Ju, S. (2026). The hsa_circ_0070354/ miR ‐4322/ RAB3B Axis Facilitates the Carcinogenesis and Development of Non‐Small Cell Lung Cancer ( NSCLC ). Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71980
Vancouver
Huang Y, Qin S, Zhang Y, Gu X, Zheng M, Ling G, et al. The hsa_circ_0070354/ miR ‐4322/ RAB3B Axis Facilitates the Carcinogenesis and Development of Non‐Small Cell Lung Cancer ( NSCLC ). Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71980
BibTeX
@article{Huang2026,
author = {Huang, Yuejiao and Qin, Shiyi and Zhang, Yu and Gu, Xinliang and Zheng, Ming and Ling, Guojie and Yang, Lei and Ju, Shaoqing},
title = {The hsa_circ_0070354/ miR ‐4322/ RAB3B Axis Facilitates the Carcinogenesis and Development of Non‐Small Cell Lung Cancer ( NSCLC )},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.71980}
}
EUVIMED